Skip to main content

Cancer Research

Vanderbilt bioengineer’s trailblazing cancer research receives $1M W. M. Keck Foundation grant

Jul. 14, 2020—A bold engineering approach by a Vanderbilt University researcher to sort breast cancer cells based on their behavior first has produced compelling data that show less migratory cells create more metastases, contradicting the prevailing hypothesis on how cancer spreads.

Read more


Breast cancer vaccine research delivers promising results

Jun. 11, 2020—Vanderbilt researchers have developed what appears to be a simple and promising treatment for breast cancer metastasis.

Read more


Potential new cancer target

Jun. 4, 2020—Vanderbilt researchers have discovered the involvement of a certain type of adenosine receptor in mediating signaling that supports tumor growth and metastasis.

Read more


Multinational consortium reports COVID-19 impact on cancer patients

Jun. 3, 2020—People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients also revealed cancer-specific factors associated with increased mortality.

Read more


Potential prostate cancer biomarkers

Sep. 19, 2019—An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

Read more


Study identifies critical regulator of tumor-specific T cell differentiation

Jun. 18, 2019—A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

Read more


Discovery aids search for cancer biomarkers

Apr. 12, 2019—A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream.

Read more


Study shows magnesium optimizes vitamin D status

Dec. 19, 2018—A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.

Read more


Limited submission opportunity: V Foundation 2018 Translational Research Awards

Mar. 2, 2018—Vanderbilt (VU + VUMC, collaboratively) anticipates the opportunity to choose one nominee for the V Foundation 2018 Translational Research Award.

Read more


Pancreatic cancer development

Aug. 31, 2017—Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.

Read more


Alex’s Lemonade grant allows new engineering grad student to join neuroblastoma fight

Jul. 5, 2017—Graduate student Kyle Garland is diving into his studies with eight weeks of intense immunology research.

Read more


Study examines new breast cancer drug combination

Apr. 20, 2017—A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.

Read more


VIEW MORE EVENTS >